Glucose-6-phosphate dehydrogenase deficiency among neonates with jaundice in Africa; systematic review and

Woldeteklehaymanot Kassahun1, Abayneh Tunta2, Atitegeb Abera3

  • 1Department of Medical Laboratory Sciences, College of Health Sciences, Woldia University, Po Box, 400, Woldia, Ethiopia.

Heliyon
|August 4, 2023
PubMed

Insights

Glucose-6-phosphate dehydrogenase (G6PD) deficiency affects nearly a quarter of African neonates with jaundice. Early screening for this genetic disorder is recommended due to its significant prevalence in the region.

Area of Science:

  • Medical Genetics
  • Neonatal Medicine
  • Public Health

Background:

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common genetic enzyme disorder.
  • It disproportionately affects populations in Africa, Asia, and the Mediterranean.
  • Neonatal jaundice is a frequent clinical presentation in newborns.

Purpose of the Study:

  • To determine the prevalence of G6PD deficiency in African neonates presenting with jaundice.
  • To synthesize existing data on G6PD deficiency in this specific demographic.

Main Methods:

  • A systematic literature search was conducted across major scientific databases.
  • Ten studies involving 1555 neonates were included and quality assessed using JBI criteria.
  • Meta-analysis with random effects modeling was employed to calculate pooled prevalence and assess heterogeneity.

Main Results:

  • The pooled prevalence of G6PD deficiency among jaundiced neonates in Africa was 24.60%.
  • Significant heterogeneity was observed across studies (I² = 100%).
  • Prevalence varied widely by country, with Nigeria reporting 49.67% and South Africa 3.14%.

Conclusions:

  • G6PD deficiency is a significant contributing factor to neonatal jaundice in Africa.
  • Further research into regional predisposing factors is warranted.
  • Screening and diagnostic testing for G6PD deficiency in neonates with jaundice should be considered.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
194
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.9K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
989
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K